APA (7th ed.) Citation

Zhao, Y., Liu, X., Ding, C., Gu, Y., Liu, W., & Liu, W. (2021). Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zhao, Yingchun, Xinglong Liu, Chuanbo Ding, Yan Gu, Wencong Liu, and Wencong Liu. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Zhao, Yingchun, et al. Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway. Frontiers Media S.A, 2021.